Rohit Kashyap - 09 Aug 2022 Form 4 Insider Report for MIMEDX GROUP, INC. (MDXG)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
11 Aug 2022, 18:30:53 UTC
Prior SEC filing
12 Apr 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ William F. Hulse, as attorney in fact for Rohit Kashyap

Key filing fact

Rohit Kashyap filed Form 4 for MIMEDX GROUP, INC. (MDXG) on 11 Aug 2022.

Key facts

  • This page summarizes Rohit Kashyap's Form 4 filing for MIMEDX GROUP, INC. (MDXG).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Aug 2022, 18:30.

Change

  • Previous filing in this sequence was filed on 12 Apr 2022.
  • Current net transaction value: -$51,939.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDXG transaction

Common Stock

Sale

Transaction value
$51,939
Shares
-12,343
Change %
-2.8%
Price
$4.21
Shares after
430,072
Date
09 Aug 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects sale of shares to cover tax withholding obligation upon vesting of previously-granted award.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .